218 related articles for article (PubMed ID: 27836794)
1. The Risk Factors, Costs, and Survival Analysis of Invasive VRE Infections at a Medical Center in Eastern Taiwan.
Jiang HL; Zhou Z; Wang LS; Fang Y; Li YH; Chu CI
Int J Infect Dis; 2017 Jan; 54():18-24. PubMed ID: 27836794
[TBL] [Abstract][Full Text] [Related]
2. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
Bhavnani SM; Drake JA; Forrest A; Deinhart JA; Jones RN; Biedenbach DJ; Ballow CH
Diagn Microbiol Infect Dis; 2000 Mar; 36(3):145-58. PubMed ID: 10729656
[TBL] [Abstract][Full Text] [Related]
3. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients.
Salgado CD
Am J Infect Control; 2008 Dec; 36(10):S175.e5-8. PubMed ID: 19084155
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant enterococcus colonization and infection in children: six-year follow-up.
Özkaya-Parlakay A; Cengiz AB; Ceyhan M; Bağdat A; Barın-Kurtoğlu Ç; Gürbüz V; Aycan AE; Kara A
Turk J Pediatr; 2014; 56(6):618-25. PubMed ID: 26388592
[TBL] [Abstract][Full Text] [Related]
5. [Vancomycin resistant enterococci in Austria].
Allerberger F; Lass-Flörl C; Dierich MP; Hirschl AM; Presterl E; Haas G; Klare I; Witte W
Wien Klin Wochenschr; 1997 May; 109(9):312-20. PubMed ID: 9265389
[TBL] [Abstract][Full Text] [Related]
6. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.
Cheah AL; Spelman T; Liew D; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
Clin Microbiol Infect; 2013 Apr; 19(4):E181-9. PubMed ID: 23398607
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin-resistant enterococci (VRE) outbreak at a university hospital in Kitakyushu, Japan: case-control studies.
Hoshuyama T; Moriguchi H; Muratani T; Matsumoto T
J Infect Chemother; 2008 Oct; 14(5):354-60. PubMed ID: 18936888
[TBL] [Abstract][Full Text] [Related]
8. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci.
Sakka V; Tsiodras S; Galani L; Antoniadou A; Souli M; Galani I; Pantelaki M; Siafakas N; Zerva L; Giamarellou H
Clin Microbiol Infect; 2008 Jan; 14(1):14-21. PubMed ID: 18005178
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for vancomycin-resistant enterococci infection and mortality in colonized patients on intensive care unit admission.
Kim YJ; Kim SI; Kim YR; Lee JY; Park YJ; Kang MW
Am J Infect Control; 2012 Dec; 40(10):1018-9. PubMed ID: 22483236
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies.
Almyroudis NG; Lesse AJ; Hahn T; Samonis G; Hazamy PA; Wongkittiroch K; Wang ES; McCarthy PL; Wetzler M; Segal BH
Infect Control Hosp Epidemiol; 2011 May; 32(5):490-6. PubMed ID: 21515980
[TBL] [Abstract][Full Text] [Related]
11. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation.
Vydra J; Shanley RM; George I; Ustun C; Smith AR; Weisdorf DJ; Young JA
Clin Infect Dis; 2012 Sep; 55(6):764-70. PubMed ID: 22693346
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and Outcomes of Vancomycin-Resistant Enterococcus Infections in the U.S. Military Health System.
Stagliano DR; Susi A; Adams DJ; Nylund CM
Mil Med; 2021 Jan; 186(Suppl 1):100-107. PubMed ID: 33499465
[TBL] [Abstract][Full Text] [Related]
13. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
Chou CH; Lee NY; Lee HC; Chang CM; Lee CC; Ko WC
J Microbiol Immunol Infect; 2012 Jun; 45(3):221-7. PubMed ID: 22578639
[TBL] [Abstract][Full Text] [Related]
14. Identification of temporal clusters and risk factors of bacteremia by nosocomial vancomycin-resistant enterococci.
da Silva NS; Muniz VD; Estofolete CF; Furtado GH; Rubio FG
Am J Infect Control; 2014 Apr; 42(4):389-92. PubMed ID: 24679566
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.
Lucas GM; Lechtzin N; Puryear DW; Yau LL; Flexner CW; Moore RD
Clin Infect Dis; 1998 May; 26(5):1127-33. PubMed ID: 9597241
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors of vancomycin-resistant enterococcus colonization in burn unit patients.
Altoparlak U; Koca O; Ozkurt Z; Akcay MN
Burns; 2011 Feb; 37(1):49-53. PubMed ID: 20926196
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for rectal colonization with vancomycin-resistant enterococci in Shiraz, Iran.
Askarian M; Afkhamzadeh R; Monabbati A; Daxboeck F; Assadian O
Int J Infect Dis; 2008 Mar; 12(2):171-5. PubMed ID: 17855141
[TBL] [Abstract][Full Text] [Related]
18. Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit.
May AK; Melton SM; McGwin G; Cross JM; Moser SA; Rue LW
Shock; 2000 Sep; 14(3):259-64. PubMed ID: 11028540
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin-resistant Enterococcus colonization in the intensive care unit: clinical outcomes and attributable costs of hospitalization.
Jung E; Byun S; Lee H; Moon SY; Lee H
Am J Infect Control; 2014 Oct; 42(10):1062-6. PubMed ID: 25278394
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin-resistant-enterococci--colonization of 24 patients on a pediatric oncology unit.
Schuster F; Graubner UB; Schmid I; Weiss M; Belohradsky BH
Klin Padiatr; 1998; 210(4):261-3. PubMed ID: 9743963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
